Jeffrey A. Schwaneke

Filings by Jeffrey A. Schwaneke span 2 companies, the busiest being Centene Corp and Agilon Health, Inc. Over a trading history stretching from 9 December 2008 to 1 April 2026, the count stands at 100 filings.

In open-market terms, that means 2 purchases worth €455k on one side and 13 sales worth €3.3M on the other. Netting one side against the other leaves €2.8M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 73 share grants and 4 option exercises.

The newest entry dates from 3 April 2026: a share grant of €14k, in Agilon Health, Inc. The latest purchase dates back some time: it was published 569 days ago, on 3 April 2025. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.